FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W114181192> ?p ?o ?g. }

• W114181192 endingPage "1530" @default.
• W114181192 startingPage "1525" @default.
• W114181192 abstract "Abstract Natural killer (NK) cell activity is severely impaired in untreated patients with hairy cell leukemia (HCL). In an attempt to investigate whether this impairment is related to a defect at the target cell binding and/or at the post target cell binding level, we evaluated the peripheral blood mononuclear cells (PBMC) of HCL patients for their ability to: (1) bind and kill K-562 NK-sensitive targets at the single cell binding level; (2) release the NK cytotoxic factor (NKCF) under different in vitro stimuli, including K-562 and phytohemoagglutinin; and (3) kill K-562 targets in a lectin-dependent cellular cytoxicity (LDCC) assay. This study demonstrates that untreated HCL patients' PBMC show a low ability to form conjugates with K-562 targets at the single cell binding level (5.7% +/- 1.0%) with respect to patients studied after treatment (9.3% +/- 1.3%) and controls (15.0% +/- 4.0%); P less than .05 and P less than .001, respectively. A decreased ability to kill the bound target was demonstrated in untreated cases (1.2% +/- 1.1%) versus patients studied after treatment and controls (12.3% +/- 1.6%, 17.0% +/- 3.1% respectively); P less than .001 in both conditions. After activation of effector cells with interleukin-2 (IL- 2) in vitro, an increase in the ability of PBMC to form conjugates with K-562 targets and kill the bound target was demonstrated in each group of patients. Moreover, IL-2 was able to increase the cytotoxicity against NK-sensitive targets in all patients tested. Evaluation of NKCF production showed that untreated patients release low levels of NKCF when PBMC were incubated in the presence of K-562 stimulators (1.8% +/- 0.7%) with respect to patients after interferon-alpha (IFN-alpha) therapy (7.6% +/- 2.1%) and controls (12.9% +/- 2.2%); P less than .02 and P less than .001, respectively. When the recognition mechanisms were bypassed by triggering the cells with lectins in an LDCC assay, we demonstrated an increase of the lytic activity in both groups of patients with respect to the baseline values. However, the cytotoxic capacity observed in untreated patients was significantly lower than that observed in subjects after IFN-alpha therapy and controls (P less than .001). These findings suggest that the impaired NK activity observed in patients with HCL is related to defects both at the target and posttarget cell binding levels." @default.
• W114181192 created "2016-06-24" @default.
• W114181192 creator A5011398547 @default.
• W114181192 creator A5013236194 @default.
• W114181192 creator A5023307044 @default.
• W114181192 creator A5029318642 @default.
• W114181192 creator A5059191835 @default.
• W114181192 creator A5066814162 @default.
• W114181192 creator A5083942494 @default.
• W114181192 creator A5084007894 @default.
• W114181192 creator A5087722204 @default.
• W114181192 date "1990-04-01" @default.
• W114181192 modified "2023-09-29" @default.
• W114181192 title "Mechanisms accounting for the defective natural killer activity in patients with hairy cell leukemia" @default.
• W114181192 cites W1483375448 @default.
• W114181192 cites W1484112158 @default.
• W114181192 cites W1506861226 @default.
• W114181192 cites W1517882827 @default.
• W114181192 cites W1523350334 @default.
• W114181192 cites W1525492803 @default.
• W114181192 cites W1547928431 @default.
• W114181192 cites W1549533251 @default.
• W114181192 cites W1645801604 @default.
• W114181192 cites W1938194695 @default.
• W114181192 cites W1951085954 @default.
• W114181192 cites W1967090918 @default.
• W114181192 cites W1977933107 @default.
• W114181192 cites W1978242550 @default.
• W114181192 cites W1995628336 @default.
• W114181192 cites W2005695087 @default.
• W114181192 cites W2009807365 @default.
• W114181192 cites W2043288453 @default.
• W114181192 cites W2043849755 @default.
• W114181192 cites W2054687940 @default.
• W114181192 cites W2057123987 @default.
• W114181192 cites W2101755459 @default.
• W114181192 cites W2127022844 @default.
• W114181192 cites W2168442794 @default.
• W114181192 cites W2334605749 @default.
• W114181192 cites W237185628 @default.
• W114181192 cites W2407337717 @default.
• W114181192 cites W2411923273 @default.
• W114181192 cites W2414770116 @default.
• W114181192 cites W3114147350 @default.
• W114181192 doi "https://doi.org/10.1182/blood.v75.7.1525.1525" @default.
• W114181192 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2317560" @default.
• W114181192 hasPublicationYear "1990" @default.
• W114181192 type Work @default.
• W114181192 sameAs 114181192 @default.
• W114181192 citedByCount "33" @default.
• W114181192 countsByYear W1141811922021 @default.
• W114181192 crossrefType "journal-article" @default.
• W114181192 hasAuthorship W114181192A5011398547 @default.
• W114181192 hasAuthorship W114181192A5013236194 @default.
• W114181192 hasAuthorship W114181192A5023307044 @default.
• W114181192 hasAuthorship W114181192A5029318642 @default.
• W114181192 hasAuthorship W114181192A5059191835 @default.
• W114181192 hasAuthorship W114181192A5066814162 @default.
• W114181192 hasAuthorship W114181192A5083942494 @default.
• W114181192 hasAuthorship W114181192A5084007894 @default.
• W114181192 hasAuthorship W114181192A5087722204 @default.
• W114181192 hasBestOaLocation W1141811921 @default.
• W114181192 hasConcept C109316439 @default.
• W114181192 hasConcept C137061746 @default.
• W114181192 hasConcept C1491633281 @default.
• W114181192 hasConcept C153911025 @default.
• W114181192 hasConcept C154317977 @default.
• W114181192 hasConcept C171122931 @default.
• W114181192 hasConcept C202751555 @default.
• W114181192 hasConcept C203014093 @default.
• W114181192 hasConcept C2777371288 @default.
• W114181192 hasConcept C2778102761 @default.
• W114181192 hasConcept C2778461978 @default.
• W114181192 hasConcept C2778690821 @default.
• W114181192 hasConcept C2780483514 @default.
• W114181192 hasConcept C2908885563 @default.
• W114181192 hasConcept C51785407 @default.
• W114181192 hasConcept C55493867 @default.
• W114181192 hasConcept C86803240 @default.
• W114181192 hasConceptScore W114181192C109316439 @default.
• W114181192 hasConceptScore W114181192C137061746 @default.
• W114181192 hasConceptScore W114181192C1491633281 @default.
• W114181192 hasConceptScore W114181192C153911025 @default.
• W114181192 hasConceptScore W114181192C154317977 @default.
• W114181192 hasConceptScore W114181192C171122931 @default.
• W114181192 hasConceptScore W114181192C202751555 @default.
• W114181192 hasConceptScore W114181192C203014093 @default.
• W114181192 hasConceptScore W114181192C2777371288 @default.
• W114181192 hasConceptScore W114181192C2778102761 @default.
• W114181192 hasConceptScore W114181192C2778461978 @default.
• W114181192 hasConceptScore W114181192C2778690821 @default.
• W114181192 hasConceptScore W114181192C2780483514 @default.
• W114181192 hasConceptScore W114181192C2908885563 @default.
• W114181192 hasConceptScore W114181192C51785407 @default.
• W114181192 hasConceptScore W114181192C55493867 @default.
• W114181192 hasConceptScore W114181192C86803240 @default.
• W114181192 hasIssue "7" @default.
• W114181192 hasLocation W1141811921 @default.

• next